Cannabis Use Disorder: Is Marijuana Addictive?

The evidence: cannabis use disorder is real, though often minimized

Cannabis use disorder is a recognized clinical diagnosis, not a judgment about recreational or medical cannabis use. Under DSM-5-TR criteria, clinicians look for at least two of 11 symptoms occurring within a 12-month period. Mild CUD involves two or three symptoms, moderate CUD involves four or five, and severe CUD involves six or more. This symptom-based approach distinguishes a disorder from use that is not causing significant impairment or distress.

“Marijuana addiction” is the more familiar search term, while cannabis use disorder is the clinical term covering a range of severity. Addiction generally describes the more compulsive end of that range. Cannabis differs from substances such as opioids or alcohol in its typical intoxication and withdrawal risks, but differences in severity do not make loss of control unreal. The broader Types of Addiction: A Complete Guide explains how substance-related disorders are assessed without ranking one person’s struggle against another.

These figures do not mean that three in every ten people who try cannabis will inevitably become addicted. Risk estimates vary with the population, diagnostic method and pattern of use. They do show that CUD is common enough to take seriously. A calm conversation about consequences is generally more useful than arguing over labels.

Signs and symptoms

Cannabis use disorder signs center on impaired control, disruption to daily life, risky use and physical adaptation. No single sign proves that someone has CUD, and tolerance alone is not enough for a diagnosis. A clinician considers how several symptoms fit together, how long they have been present and whether another medical or mental health issue better explains them.

The practical impact can be subtle. Someone may keep working while becoming increasingly dependent on cannabis to sleep, manage emotions, socialize or feel normal. Warning signs can also include organizing the day around use, hiding the amount used, repeatedly breaking personal limits or returning to cannabis quickly after sincere attempts to stop. The Signs You (or a Loved One) Need Rehab: Self-Assessment can help organize concerns, but it cannot replace a clinical evaluation.

Anxiety, depression, trauma symptoms, attention difficulties and other substance use can overlap with—or contribute to—problematic cannabis use. An assessment should therefore consider the whole picture rather than assuming every symptom comes from marijuana. People experiencing both concerns may benefit from the integrated approach described in Co-Occurring Disorders: Addiction & Mental Health.

Who's at higher risk: frequency, age of first use, potency trends

Risk is not evenly distributed. The CDC identifies frequent use and beginning during youth or adolescence as important risk factors for cannabis use disorder. Daily or near-daily use creates more opportunities for tolerance, withdrawal and habitual coping patterns to develop, while starting young may establish those patterns during a period of ongoing development.

• Frequency: Using on more days, particularly daily or near daily, is associated with greater CUD risk than occasional use.
• Age of first use: People who begin during adolescence face greater risk than those who start later.
• Product strength: Higher-THC products produce stronger intoxicating effects and may make unintentional overconsumption more likely.
• Method of use: Concentrates used through vaping or dabbing can deliver very high THC exposure, making product type relevant alongside frequency.
• Personal context: Stress, mental health symptoms and other substance use should be explored because they can affect why a person uses and what support is appropriate.

Cannabis products have also changed. The US Drug Enforcement Administration reported that average delta-9 THC potency in tested plant material reached about 16% in 2022, compared with roughly 4% in the late 1990s. Separately, the CDC cites a study of online dispensary products in three states that found an average THC concentration of 22%, with products ranging from 0% to 45%. These figures describe different samples, but both illustrate why today’s products cannot always be compared with cannabis used decades ago.

The relationship between potency and addiction is still being studied. A recent systematic review found evidence suggestive of an association between higher-potency cannabis and problematic use or CUD symptoms, but rated the overall certainty as very low. It is therefore reasonable to treat potency as a possible risk factor without claiming that THC percentage alone determines who becomes addicted.

For parents and caregivers, early changes in motivation, attendance, friendships or emotional wellbeing deserve a supportive conversation rather than punishment or panic. The Teen Substance Use Trends Report and Rehab for Teens vs Adults: Key Differences provide additional age-specific context.

Withdrawal — real but usually non-medical

Cannabis withdrawal can occur when someone who has been using regularly or heavily stops or substantially reduces THC intake. A review of more than 20,000 regular or dependent users estimated that approximately 47% experienced a withdrawal syndrome, although prevalence varied substantially between community, outpatient and inpatient samples.

• Irritability, anger or feeling unusually on edge
• Anxiety or restlessness
• Difficulty falling asleep, disrupted sleep or vivid dreams
• Reduced appetite and, in some cases, weight loss
• Low mood
• Cravings for cannabis
• Less common physical discomfort such as headache, sweating, chills, stomach pain or muscle tension

Symptoms commonly begin within 24–48 hours, are often most intense around days two to six, and generally ease over the following one to two weeks. Sleep or mood disruption may last several weeks in some heavy users. Unlike withdrawal from certain other substances, uncomplicated cannabis withdrawal usually does not require inpatient medical detox, but its discomfort can contribute to rapid return to use.

Supportive counseling, psychoeducation, sleep planning, hydration and a structured routine are commonly used during uncomplicated withdrawal. No medication is currently approved specifically for cannabis withdrawal, although a doctor may sometimes address individual symptoms after reviewing the person’s health and other medications. For broader substance-specific timelines and safety differences, see Withdrawal Symptoms & Timelines by Substance and Medical Detox: What to Expect.

Treatment approaches: mostly behavioral/therapy-based

Treatment for cannabis use disorder is usually built around behavioral therapies rather than a medication that directly treats the disorder. No medication is currently approved by the US Food and Drug Administration specifically for marijuana use disorder, although research continues. Treatment goals may involve abstinence or an agreed reduction plan, depending on clinical needs, safety, the person’s preferences and whether moderation has been sustainable.

A 2016 Cochrane review found that psychosocial treatment could reduce cannabis-use frequency and dependence severity compared with minimal or no treatment, particularly in the short term. The most consistent support was for more intensive combinations of motivational enhancement therapy and CBT, sometimes with contingency management. A newer review of 22 randomized trials also found potentially improved abstinence with motivational enhancement combined with CBT, but judged much of the evidence low or very low certainty. Results vary, and treatment should be adjusted rather than treated as a guaranteed formula.

The Cognitive Behavioral Therapy (CBT) for Addiction guide looks more closely at one of these approaches, while Types of Therapy Used in Addiction Treatment explains additional options. Treatment may also include family involvement, peer support, relapse-prevention planning and direct care for anxiety, depression, trauma or another substance use disorder.

Many people can begin with outpatient counseling, especially when they have stable housing, supportive relationships and no acute safety concerns. More structured outpatient, day or residential treatment may be appropriate when cannabis use is severe, the home environment makes change difficult, earlier outpatient attempts have not helped, or significant co-occurring conditions require closer support. The choice is individualized rather than based on the substance name alone; see Inpatient vs Outpatient Rehab: Which Is Right for You? and Levels of Care in Addiction Treatment: Detox to Aftercare.

A useful first step is a confidential assessment with a doctor, addiction clinician or treatment admissions team. They can review the pattern of use, withdrawal history, mental health, other substances, medications and daily circumstances, then recommend an appropriate level of care. Asking for an assessment does not commit someone to residential rehab—and it can provide clarity before the problem becomes more disruptive.